Cargando…

Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection

Prostate cancer (PCa) diagnosis based on patient urine analysis provides non-invasive and promising method as compared to biopsy and a prostate-specific antigen (PSA) test. This study was conceived to investigate whether Integrin alpha V (ITGAV) protein is present in urine and assess the urinary ITG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zemskova, Marina Y., Marinets, Maria V., Sivkov, Andrey V., Pavlova, Julia V., Shibaev, Andrey N., Sorokin, Konstantin S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006463/ https://www.ncbi.nlm.nih.gov/pubmed/33791193 http://dx.doi.org/10.3389/fonc.2020.610647

Ejemplares similares

Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients
por: Teixeira, Silvia A., et al.
Publicado: (2022)

Role of Integrin Alpha4 in Drug Resistance of Leukemia
por: Shishido, Stephanie, et al.
Publicado: (2014)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Urine- and Blood-Based Molecular Profiling of Human Prostate Cancer
por: Chen, Gang, et al.
Publicado: (2022)

Novel Trends in the Development of Surfactant-Based Hydraulic Fracturing Fluids: A Review
por: Shibaev, Andrey V., et al.
Publicado: (2021)

Urine markers and prostate cancer
por: Wilkosz, Jacek, et al.
Publicado: (2011)

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
por: Pifano, Marina, et al.
Publicado: (2017)

Synthesis and Evaluation of Properties of an Additive Based on Bismuth Titanates for Cement Systems
por: Samchenko, Svetlana V., et al.
Publicado: (2023)

Regulation of Integrin Subunit Alpha 2 by miR-135b-5p Modulates Chemoresistance in Gastric Cancer
por: Wang, Qi, et al.
Publicado: (2020)

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020)

Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017)

Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma
por: Voronova, Veronika, et al.
Publicado: (2020)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Metastatic bladder tumor from prostate cancer causing a ball valve-like obstruction in urination
por: Imanaka, Takahiro, et al.
Publicado: (2020)

Reparative properties of human glioblastoma cells after single exposure to a wide range of X-ray doses
por: Pavlova, Galina, et al.
Publicado: (2022)

Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

5-ALA-guided tumor resection during awake speech mapping in gliomas located in eloquent speech areas: Single-center experience
por: Goryaynov, Sergey A., et al.
Publicado: (2022)

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
por: Kemper, Marius, et al.
Publicado: (2021)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer
por: Suhovskih, Anastasia V., et al.
Publicado: (2014)

Tumor Targeting via Integrin Ligands
por: Marelli, Udaya Kiran, et al.
Publicado: (2013)

Radiomics-Based Machine Learning Models for Predicting P504s/P63 Immunohistochemical Expression: A Noninvasive Diagnostic Tool for Prostate Cancer
por: Liu, Yun-Fan, et al.
Publicado: (2022)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Sivkov, Andrey, et al.
Publicado: (2021)

Differential responses to (223)Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
por: Guerra Liberal, Francisco D. C., et al.
Publicado: (2022)

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
por: Connell, Shea P., et al.
Publicado: (2019)

EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
por: Cheaito, Katia A., et al.
Publicado: (2019)

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
por: Ripoll, Giselle V., et al.
Publicado: (2020)

Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target
por: Liu, Chun-Shan, et al.
Publicado: (2020)

Pilocytic Astrocytoma Enlargement Following Irradiation: Relapse or Pseudoprogression?
por: Trunin, Yury, et al.
Publicado: (2017)

Cadherins, Selectins, and Integrins in CAM-DR in Leukemia
por: Kim, Hye Na, et al.
Publicado: (2020)

Integrin-Mediated Tumorigenesis and Its Therapeutic Applications
por: Li, Qingling, et al.
Publicado: (2022)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
por: Charpentier, Marine, et al.
Publicado: (2021)

Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis
por: Dmitriev, Alexey A., et al.
Publicado: (2015)

A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer
por: McNally, Christopher J., et al.
Publicado: (2022)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

Comprehensive Characterization of Integrin Subunit Genes in Human Cancers
por: Cui, Kaisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ptktbs8kbpnv5dju5723j7slch